Mixture of Standardized and Non-Standardized Coastal Grasses is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Antigen Laboratories, Inc.. The primary component is Poa Pratensis Pollen; Dactylis Glomerata Pollen; Lolium Perenne Pollen; Agrostis Gigantea Pollen; Anthoxanthum Odoratum Pollen; Phleum Pratense Pollen; Poa Compressa Pollen; Arrhenatherum Elatius Pollen; Holcus Lanatus Pollen.
| Product ID | 49288-0242_bb0c98b2-aaa8-49c4-887a-928e3937769c |
| NDC | 49288-0242 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Mixture of Standardized and Non-Standardized Coastal Grasses |
| Generic Name | Mixture Of Standardized And Non-standardized Coastal Grasses |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1997-06-13 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103421 |
| Labeler Name | Antigen Laboratories, Inc. |
| Substance Name | POA PRATENSIS POLLEN; DACTYLIS GLOMERATA POLLEN; LOLIUM PERENNE POLLEN; AGROSTIS GIGANTEA POLLEN; ANTHOXANTHUM ODORATUM POLLEN; PHLEUM PRATENSE POLLEN; POA COMPRESSA POLLEN; ARRHENATHERUM ELATIUS POLLEN; HOLCUS LANATUS POLLEN |
| Active Ingredient Strength | 11111 [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; [BAU]/mL; g/mL; g/mL; g/mL |
| Pharm Classes | Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 1997-06-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | BLA |
| Application Number | BLA103421 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1997-06-13 |
| Inactivation Date | 2019-10-21 |
| Marketing Category | BLA |
| Application Number | BLA103421 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1997-06-13 |
| Inactivation Date | 2019-10-21 |
| Marketing Category | BLA |
| Application Number | BLA103421 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1997-06-13 |
| Inactivation Date | 2019-10-21 |
| Ingredient | Strength |
|---|---|
| POA PRATENSIS POLLEN | 11111 [BAU]/mL |
| SPL SET ID: | c08f73ff-4f15-449c-9507-c422367f106b |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |